WO2004084923A1 - Antistress agent - Google Patents

Antistress agent Download PDF

Info

Publication number
WO2004084923A1
WO2004084923A1 PCT/JP2004/003898 JP2004003898W WO2004084923A1 WO 2004084923 A1 WO2004084923 A1 WO 2004084923A1 JP 2004003898 W JP2004003898 W JP 2004003898W WO 2004084923 A1 WO2004084923 A1 WO 2004084923A1
Authority
WO
WIPO (PCT)
Prior art keywords
seafood
fish
lactobacillus
lactic acid
acid bacteria
Prior art date
Application number
PCT/JP2004/003898
Other languages
French (fr)
Japanese (ja)
Inventor
Shunsuke Koshio
Yoshihiro Yamamoto
Original Assignee
Takeda Food Products, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Food Products, Ltd. filed Critical Takeda Food Products, Ltd.
Priority to JP2005504047A priority Critical patent/JP4813902B2/en
Publication of WO2004084923A1 publication Critical patent/WO2004084923A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish
    • Y02A40/818Alternative feeds for fish, e.g. in aquacultures

Definitions

  • the present invention relates to an anti-stress agent that imparts resistance to seafood against the adverse effects of stress.
  • the present invention also relates to an aquaculture method using the same.
  • antibiotics drugs such as antibiotics have been widely used.
  • antibiotics and other drugs are effective to some extent, but there are safety problems such as residues in animals and environmental pollution, and adverse effects due to the emergence of resistant bacteria. Heading in the direction.
  • viable bacteria include photosynthetic bacteria (PSB), mixed microorganisms (trade name “Cycle”: manufactured by Sudo Co., Ltd., trade name “Super Bio”: manufactured by Tomofuji Co., Ltd.), and the like.
  • PSB photosynthetic bacteria
  • mixed microorganisms trade name “Cycle”: manufactured by Sudo Co., Ltd., trade name “Super Bio”: manufactured by Tomofuji Co., Ltd.
  • many of these viable bacteria agents are room temperature storage liquid types, and the viable cell retention rate before use is generally poor.
  • An object of the present invention is to provide a preparation for effectively preventing or treating stress in seafood.
  • the present inventors have unexpectedly and surprisingly found that a dead cell of lactic acid bacteria or a processed product thereof is not stressed for fish and shellfish. It has been found that it has an excellent effect on the prevention or treatment of the disease.
  • the dead cells are used as active ingredients instead of living lactic acid bacteria, the present inventors can easily handle the active ingredients and process management easily when producing anti-stress agents.
  • the active ingredient in the formulated product is highly stable during storage and in water I also learned that.
  • An anti-stress agent for seafood characterized by containing dead lactic acid bacteria or a processed product thereof
  • Lactobacillus Lactobacillus plantarum Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei fermentunu, Lactobacillus paracasei, Lactobacillus buchneri, Lactobacillus delbrueckii, Lactobacillus rhamnosus (Lactobacillus rhamnosus octo) thermophi lus, Enterococcus faecalis> Enterococcus faecium, Lactococcus lactis, Lactococcus plantarum (Lact) ococcus pi ant arum) or Bifidobacterium thermophi lum, Bifidobacterium longum Bifidobacterium breve Bifidobacterium breve A
  • the ratio of dead lactic acid bacteria or treated product thereof is 0.1 to 50% by mass relative to the total amount, according to any one of (1) to (7) above Anti-stress agent for seafood,
  • a method for preventing or treating seafood stress comprising feeding the seafood with the antistress agent for seafood according to any one of (1) to (8) above, (12) Death of lactic acid bacteria
  • a method for preventing or treating stress in seafood characterized by feeding the body or processed product thereof to seafood at a rate of 0.0005 to 75 mg per day per kg of seafood;
  • a method for suppressing a rise in serum cortisol in seafood comprising using the antistress agent for seafood according to any one of (1) to (8) above,
  • lactic acid bacteria any known lactic acid bacteria such as Lactobacillus genus, Streptococcus genus, Enterococcus genus, Lactococcus genus or Bifidobacterium can be used.
  • Lactobacillus pi ant arum Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus brevis, Lactobacillus casei, Lactobacillus casei, Lactobacillus fermentum, Lactobacillus paracasei, Lactobacillus buchneri, Lactobacillus buchneri, Lactobacillus delbruecki i, Lactobacillus delbruecki i, Lactobacillus Streptococcus thermophilus, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Lactococcus lactis (Lactococcus plantarum), Bifidobacterium thermophilum, Bifidobacterium longum, Bifidobacterium breve and the like. Of these various lactobacilli, Lactobacillus plantarum is preferred.
  • Lactobacillus plantarum L 1 137 can be mentioned as a representative of the bacteria belonging to Lactobacillus plantarum used in the present invention. This bacteria is an independent administrative agency, National Institute of Advanced Industrial Science and Technology. Deposited at the center under the deposit number FERM BP-08607 (transferred from FE RM P-15317 deposited on November 30, 1995).
  • the Lactobacillus plantarum used in the present invention further includes Lactobacillus plantarum. (Lactobacillus pi ant arum) JCM 1 1 4 9 Reference strain and Lactobacillus plantarum L— 0 5 1 (Microbiken No. 1 1 9 1 2) are included. Lactobacillus planum lamb L— 1 3 7 is most preferred.
  • the bacterium used in the present invention can be obtained by culturing in a medium such as a natural medium, a synthetic medium, or a semi-synthetic medium.
  • a medium containing a nitrogen source and a carbon source is used as the medium.
  • Nitrogen sources include, for example, meat extract, peptone, gluten, casein, yeast extract, amino acids, etc.
  • carbon sources include, for example, glucose, xylose, flax 1 ⁇ 1s, wild boar, maltose, water Me, soup, starch, bacus, bran, molasses, glycerin, etc. are used.
  • ammonium sulfate, potassium phosphate, magnesium chloride, sodium chloride, iron, manganese, molybdenum, and the like can be added as inorganic substances, and various vitamins and the like can be added.
  • the culture temperature is about 25 to 40 ° C, preferably about 27 to 35 ° C
  • the culture time is about 12 to 48 hours, and aeration and shaking may be performed.
  • the pH of the medium is about 3-6, preferably about 4-6.
  • the cells may be collected and then killed cells may be prepared, or the cells in the culture solution may be changed to dead cells without separating the cells from the culture solution. Bacteria may be collected.
  • Dead cells can be obtained by inactivating the collected live cells or the culture medium containing the live cells, for example, by heating, ultraviolet irradiation, formalin treatment, or the like.
  • the heating temperature is usually about 60 to 100 ° C., preferably about 70 to 9.
  • the heating means may be a known means using a heater.
  • the heating time is usually about 5 to 40 minutes, preferably about 10 to 30 minutes after reaching the desired temperature.
  • the treated product of dead cells can be obtained, for example, by freeze-drying or spray-drying dead cells.
  • appropriate excipients such as dextrin and cellulose to dead cells, This can also be obtained by freeze drying or spray drying.
  • the processed product of dead cells may also be an extract of dead cells.
  • the seafood in the present invention is not particularly limited, and may be any of freshwater fish, saltwater fish, and crustaceans, and may be any of cultured fish and ornamental fish.
  • freshwater fish include eel, carp, rainbow trout, ayu, tilapia, crucian carp, goldfish (e.g., lunchyu, Japanese gold, comet, vermilion gold, Dutch shigashira, dice, etc.), guppy, apistogramma, and dish.
  • Examples of saltwater fish include bluefin tuna, puri, Thailand, coho salmon, horse mackerel, flounder, flounder, blackfish, trough, and amberjack.
  • salmon trout and the like can be mentioned as belonging to both freshwater fish and saltwater fish.
  • crustaceans include prawns, black taiga, ushebi, kolayebi, and crab.
  • the seafood as described above may be any of larvae (including small fish, larvae, fry, and juveniles) and adult fish.
  • the anti-stress agent of the present invention may be a killed lactic acid bacterium or a processed product thereof, or a preparation obtained by mixing dead cells or a processed product thereof with an excipient or diluent.
  • the blending ratio of dead cells or processed product thereof to the whole preparation is preferably about 0.1 to 95% by mass, more preferably about 0.1 to 50% by mass.
  • the dosage form include pellets, tablets, liquids, powders, granules, and pastes. Such preparations can be brought into contact with seafood or given orally.
  • Solid excipients or diluents include, for example, fish meal, bone meal, skim milk, cottonseed meal, wheat flour, wheat germ, rice bran, brewer's yeast, cellulose, vitamins (eg / 3-strength rotin, vitamin D 3 , Menadione-sodium hydrogen sulfite, —tocopherol, thiamine—nitrate, riboflavin, pyridoxine—hydrochloride, cyanocobalamin, piotin, inositol, nicotinic acid, calcium pantothenate, folic acid, choline choline, paraaminobenzoic acid or vitamin C Etc.), mineral mixes (eg magnesium sulfate, disodium phosphate, 2-natto phosphate) And so-called feed materials such as potassium potassium, iron citrate, calcium lactate, aluminum hydroxide, sulfite sulfate, copper sulfate, manganese
  • liquid excipient or diluent examples include water or a mixture of water and alcohol.
  • the antistress agent of the present invention can be easily produced by mixing dead bacteria of Lactobacillus plantum or a processed product thereof with the above-mentioned excipient or diluent. When mixing, it may be heated as desired to obtain a flaky preparation. The preparation of the present invention thus produced may be used as a feed for seafood. When used as feed, the concentration of dead cells in the feed or processed product thereof is preferably more than about 0 ppm and not more than 200 ppm, more preferably from about 0.1 to 200 ppm. is there.
  • the feeding amount of the antistress agent for seafood of the present invention is 0.05 to 75 mg per day per kg body weight of the seafood in terms of the above-mentioned dead cells of lactic acid bacteria or processed products thereof. It is preferable that it is 0.05 to 7.5 mg.
  • One possible mechanism for the anti-stress effect of the preparation of the present invention on fish and shellfish is to suppress the rise in serum cortisol.
  • the neuro-endocrine system first responds to stress and secretes neurotransmitters and hormones.
  • Physiological effects of secreted neurotransmitters and hormones can cause physiological changes in the body, which can lead to growth inhibition, reproductive function and decreased resistance to disease.
  • the effects of these stresses are the result of the integration of various substances such as neurotransmitters and hormones, but it is said that cortisol plays the leading role (cultured 2001. No. 1 1, 56- 59). Therefore, it is possible to resist the adverse effects of stress as described above by suppressing the rise in cortisol.
  • the antistress agent for seafood of the present invention has an action of suppressing the rise of cortisol in seafood, and when administered to seafood, the stress of seafood can be effectively prevented or treated.
  • the weight of seafood increases, the growth of seafood increases, The survival rate is improved and the taste quality of seafood (eg, texture, flavor, etc.) is improved.
  • strain was inoculated into 6 L of a medium containing 0.001% and 0.05% sucrose fatty acid ester, and cultured at 32 for 24 hours. After culturing, the culture was centrifuged at 5000 rpm for 35 minutes to collect the cells.
  • the obtained bacterial cells were well dispersed in physiological saline and centrifuged at 5000 rpm for 35 minutes, and then the supernatant was removed to collect the bacterial cells. After repeating this operation three times, the cells were dispersed in ion-exchanged water, heated at 70 ° C. for 10 minutes, and then freeze-dried to obtain about 7 g of heated dead cells. (Manufacture of pellets from dead cells)
  • Brown Fish Meal 65 6 parts by weight, —Starch 3.4 parts by weight, dextrin 3.4 parts by weight, soy lecithin 4.2 parts by weight, sodium menadione hydrogen bisulfate 0.0124 parts by weight, thiamine mononitrate 0.01797 Parts by mass, riboflavin 0.05991 parts by mass, pyridoxine monohydrochloride 0.014 8 parts by mass, cyanobalamine 0.00002 parts by mass, cellulose 0.5986 9 parts by mass, piotin 0.00191 parts by mass, inositol 1.
  • vitamin-containing ⁇ liver oil ⁇ fF oil 7 parts by weight, ⁇ Ichirotin 0.0996 parts by weight, vitamin D 3 0.00301 parts by weight, ⁇ -tocopherol 0.111993 parts by weight
  • ultrasonic washing machine The mixture was added using Lactobacillus branulam L_137 heated dead cells are added to this to a predetermined concentration, then ⁇ -cell mouthwater is added, and the total amount is adjusted to 100 parts by mass to feed dead cells. It was.
  • the addition concentration of the heated dead cells was set to 5 levels of 0, 0.2, 2, 20, and 200 ppm in the dead cell-containing feed, respectively.
  • Red sea bream larvae (weight: 0.9 ⁇ 0. lg) were placed in a circulating 30L circular polycarbonate tank, 15 each, and 3 tanks were set for each test feed, and the test feed was taken twice a day in the morning and evening. 5-7% of the body weight was given, the water change rate was 2.4 LZ, and the water temperature was maintained at 20. 0 ° C.
  • blood was collected from the tail capillaries. After preparing serum from this blood, the amount of cortisol in the serum was measured by ELISA. The results are shown in Table 2. Table 2
  • Lactobacillus plantarum L-1 137 strain (Lactobacillus plantarum L-137) heat-killed cells containing 0.2 ppm or more of the feed group were fed in the test group.
  • Cortisol in red sea bream serum was significantly lower than in the control group that received a diet that did not contain dead cells.
  • Lactobacillus planon Talam L-137 (Lactobacillus plantarum L-137) was cultured at 32 ° C for 24 hours, and the culture was heat-treated at 80 for 20 minutes. Thereafter, the culture solution was washed and concentrated with a filter concentration device while adding water to obtain a heated dead cell solution. Dextrin was added to the obtained heated dead cell solution and spray-dried to obtain a treated product of dead cells containing 18% of heated dead cells.
  • composition of the vitamin mix is shown in Table 3, and the composition of the mineral mix is shown in Table 4.
  • the mineral mix and vitamin mix were the same as in Example 2.
  • test group is overwhelmingly preferred for the overall evaluation of the texture, flavor, and texture, appearance, and flavor. It has been shown. In particular, regarding the texture, the test group was more elastic and delicious, and the test group had a sense of crispiness and was often rated delicious. Regarding the flavor, the test group was more evaluated as having no odor.
  • the anti-stress agent of the present invention can effectively prevent or treat seafood stress.

Abstract

An antistress agent for fishes and shellfishes characterized by containing dead lactic acid bacterium cells optionally having been processed. This antistress agent is useful in preventing or treating stresses in fishes and shellfishes.

Description

抗ストレス剤 Anti-stress agent
技術分野 Technical field
本発明は、 ストレスによる悪影響に対して魚介類に抵抗性を付与する抗スト レス剤に関する。 本発明はまた、 それを使用する養殖方法にも関する。  The present invention relates to an anti-stress agent that imparts resistance to seafood against the adverse effects of stress. The present invention also relates to an aquaculture method using the same.
明 背景技術 田 従来、 各種魚介類の養殖や観賞用水生動物の飼育を行なう場合、 飼育育成環 境の過密、 温度の変化又は水質悪化、 或いは輸送等のストレスによって、 これ ら水生動物は体調を崩し、 退色や変色、 疾病に対する抵坊力の低下、 摂餌の悪 化、 体格の貧弱化、 肉質や脂乗りの低下等の弊害が生じることは知られている (特開平 0 9— 3 0 8 4 4 0号公報)。 このようなストレスによる弊害を下記 に例示する。  In the past, when aquaculture and aquatic animals were bred for various seafood, these aquatic animals were in physical condition due to overcrowding of the rearing environment, temperature changes or deterioration of water quality, or stress such as transportation. It has been known that such problems as disintegration, fading and discoloration, decrease in fighting force against diseases, poor feeding, poor physique, and deterioration in meat quality and fat riding (Japanese Patent Laid-Open No. 0-9-30) 8 4 4 0). The following are examples of adverse effects caused by such stress.
プリの稚魚については、 飼育水槽内に攻撃する個体 (攻撃個体) と攻撃され る個体 (劣位個体) とがあり、 劣位個体は強度のストレス状態におかれ、 体重 増加に支障がでる (平成 8年度日本水産学会春季大会講演要旨集、 p 6 4、 1 9 9 6 )。  As for the juvenile fish, there are attacking individuals (attacking individuals) and attacking individuals (inferior individuals) in the breeding aquarium, and the inferior individuals are placed under intense stress, which hinders weight gain (Heisei 8) Abstracts of Annual Meeting of the Japanese Society of Fisheries Science, p 6 4, 1 9 9 6).
ァュについては、 なわばりを持つことのできない非なわばり個体では、 移動 範囲が狭く、 摂餌頻度が低いことから、 なわばり個体と比較して成長率が低い との報告 (平成 8年度日本水産学会春季大会講演要旨集、 p 4 3、 1 9 9 6 ) がある。 ストレスのかかった劣位個体で、 非なわばりァュと同様成長率が低く なると考えられる。  As for chu, non-territory individuals who cannot have territory report a low growth rate compared to territory territory due to its narrow movement range and low feeding frequency. Abstracts of Annual Meeting of the Fisheries Society of Japan, p 4 3, 1 9 9 6) It is considered to be a stressed inferior individual with a low growth rate, as is the case with non-female individuals.
また、 ヒラメのように神経質な魚では、 選別のための池替えや池の掃除など の後には、そのストレスによつて摂餌が悪くなる。 トラフグでもヒラメと同様、 池替えの後には摂餌が悪くなる。 In addition, in a fish that is nervous, such as flounder, the feeding becomes worse due to the stress after changing the pond for sorting or cleaning the pond. Just like flounder, Feeding worsens after pond change.
さらに、 観賞魚は、 ストレスによって皮膚が退色及び変色し、 本来鮮やかな 色彩が消失する。  In addition, ornamental fish lose their original vivid colors due to skin fade and discoloration caused by stress.
これらの悪影響を防止するため、 抗生物質等の薬剤が汎用された。 しかしな がら、 抗生物質等の薬剤はある程度の効果はあるが、 動物体内への残留、 環境 汚染等の安全性の問題や、 耐性菌の出現による弊害があり、 現在は薬剤の使用 を差し控える方向に向かっている。 また、 抗生物質製剤以外に生菌剤も知られ ている。 生菌剤としては、 光合成細菌 (P S B )、 混合微生物 (商品名 「サイ クル」: (株) スドー製、 商品名 「スーパーバイオ」:(株) トモフジ製) 等が挙 げられる。しかしながら、これら生菌剤の多くは、常温保存液体タイプであり、 使用前の生菌保持率が概して悪い。 そのため、 使用に際しての生菌数が不充分 であったり、 使用環境条件が少しでも過酷になると効果が認められなかったり して、 適性条件での使用が困難である場合が多く、 目に見えて体質を改善し得 るものは、 未だ実用化に至っていないのが現状である。 生菌である以上その生 菌数の維持には、 注意を払わなくてはならないから、 その取り扱いが困難であ り、 工程管理が容易ではなかった。 発明の開示  In order to prevent these adverse effects, drugs such as antibiotics have been widely used. However, antibiotics and other drugs are effective to some extent, but there are safety problems such as residues in animals and environmental pollution, and adverse effects due to the emergence of resistant bacteria. Heading in the direction. In addition to antibiotic preparations, viable bacteria are also known. Examples of viable bacteria include photosynthetic bacteria (PSB), mixed microorganisms (trade name “Cycle”: manufactured by Sudo Co., Ltd., trade name “Super Bio”: manufactured by Tomofuji Co., Ltd.), and the like. However, many of these viable bacteria agents are room temperature storage liquid types, and the viable cell retention rate before use is generally poor. For this reason, there are many cases where the number of viable bacteria is insufficient when used, or the effect is not recognized if the usage environment becomes too harsh, making it difficult to use under appropriate conditions. The things that can improve the constitution are not yet in practical use. As long as it is a viable cell, care must be taken to maintain the viable cell count, making it difficult to handle and process management. Disclosure of the invention
本発明は、 魚介類のストレスを有効に予防又は治療する製剤を提供すること を目的とする。  An object of the present invention is to provide a preparation for effectively preventing or treating stress in seafood.
本発明者らは、 上記課題を達成するために鋭意検討した結果、 乳酸菌の生菌 体ではなく、 予想外かつ驚くべきことに、 乳酸菌の死菌体又はその処理物が魚 介類用のストレスの予防又は治療に優れた効果を奏することを知見した。 また、 本発明者らは、 乳酸菌の生菌体ではなく、 有効成分として死菌体を使用する場 合は、 抗ストレス剤の製造に際して、 有効成分が取り扱いやすく、 工程管理が 容易であり、 製造された製剤中の有効成分が保存時並びに水中で安定性に富む ことをも知見した。 As a result of intensive studies to achieve the above-mentioned problems, the present inventors have unexpectedly and surprisingly found that a dead cell of lactic acid bacteria or a processed product thereof is not stressed for fish and shellfish. It has been found that it has an excellent effect on the prevention or treatment of the disease. In addition, when the dead cells are used as active ingredients instead of living lactic acid bacteria, the present inventors can easily handle the active ingredients and process management easily when producing anti-stress agents. The active ingredient in the formulated product is highly stable during storage and in water I also learned that.
すなわち、 本発明は、  That is, the present invention
( 1 ) 乳酸菌の死菌体又はその処理物を含有することを特徴とする魚介類 用抗ストレス剤、  (1) An anti-stress agent for seafood characterized by containing dead lactic acid bacteria or a processed product thereof,
(2) 乳酸菌が、ラクトバチルス 'プランタラム(Lactobacillus plantarum)、 ラクトバチラス ·ァシドフィラス(Lactobacillus acidophilus), ラクトバチ ルス · ブレビス(Lactobacillus brevis) , ラク トバチルス · カゼィ (Lactobacillus casei)、 ラクト / チフレス ·フアーメンタム (Lactobacillus fermentunu、 ラク卜^チフレス · / ラカセィ (Lactobacillus paracasei), ラ クトバチルス ·ブフネリ (Lactobacillus buchneri), ラクトバチルス ·デル ブルツキ一 (Lactobacillus delbrueckii)、 ラクトバチルス · ラムノサス (Lactobacillus rhamnosus )、 ストレフ トコッカス - サーモフィ ラス (Streptococcus thermophi lus)、 ェンテロコ ッカス · フエ一力 リス (Enterococcus faecalis) > ェンテロコッカス ·ファシゥム (Enterococcus faecium), ラクトコッカス ·ラクテイス (Lactococcus lactis)、 ラクトコッ カス ·プランタラム (Lactococcus pi ant arum) 又はビフィドバクテリゥム · サーモフィラム (Bifidobacterium thermophi lum)、 ビフイドパクテリゥム ' ロンガム (Bifidobacterium longum) ビフィ ドバクテリゥム · ブレービ (Bifidobacterium breve) である上記 (1) 記載の魚介類用抗ストレス剤、 (3) 乳酸菌の死菌体が乳酸菌の加熱処理により得られる死菌体であるこ とを特徴とする上記 (1) 又は (2) に記載の魚介類用抗ストレス剤、  (2) Lactobacillus Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei fermentunu, Lactobacillus paracasei, Lactobacillus buchneri, Lactobacillus delbrueckii, Lactobacillus rhamnosus (Lactobacillus rhamnosus octo) thermophi lus, Enterococcus faecalis> Enterococcus faecium, Lactococcus lactis, Lactococcus plantarum (Lact) ococcus pi ant arum) or Bifidobacterium thermophi lum, Bifidobacterium longum Bifidobacterium breve Bifidobacterium breve A stress agent, (3) the anti-stress agent for fish and shellfish according to (1) or (2) above, wherein the dead cells of lactic acid bacteria are dead cells obtained by heat treatment of lactic acid bacteria,
(4) 乳酸菌の死菌体がラクトバチルス,プランタラム L一 1 37株 (Lactobacillus plantarumL-137, 受託番号 FERM BP-08607) の加熱処理死菌体であることを特徴とする上記 (1) 〜 (3) のいずれかに記 載の魚介類用抗ストレス剤、  (4) The above-mentioned (1) to (1), wherein the dead cells of lactic acid bacteria are heat-treated dead cells of Lactobacillus plantarumL-137 strain (Accession number FERM BP-08607) (3) the anti-stress agent for seafood described in any of the above,
(5) 魚介類が養殖魚類又は観賞魚類であることを特徴とする上記 (1) 〜 (4) のいずれかに記載の魚介類用抗ストレス剤、 (5) The above (1) characterized in that the seafood is farmed fish or ornamental fish ~ Antistress agent for fish and shellfish according to any one of (4),
(6) 魚介類が、 海水魚又は淡水魚であることを特徴とする上記 (1) 〜 (5) のいずれかに記載の魚介類用抗ストレス剤、  (6) The antistress agent for seafood according to any one of the above (1) to (5), wherein the seafood is a saltwater fish or a freshwater fish,
(7) 魚介類が、 仔稚魚であることを特徴とする上記 (1) 〜 (6) のい ずれかに記載の魚介類用抗ストレス剤、  (7) The antistress agent for seafood according to any one of (1) to (6) above, wherein the seafood is a larva
(8) 乳酸菌の死菌体又はその処理物の配合割合が、 全体量に対して 0. 1~50質量%であることを特徴とする上記 (1) 〜 (7) のいずれかに記載 の魚介類用抗ストレス剤、  (8) The ratio of dead lactic acid bacteria or treated product thereof is 0.1 to 50% by mass relative to the total amount, according to any one of (1) to (7) above Anti-stress agent for seafood,
(9) 上記 (1) 〜 (8) のいずれかに記載の魚介類用抗ストレス剤を含 有する魚介類用飼料、  (9) Seafood feed comprising the antistress agent for fish and shellfish according to any one of (1) to (8) above,
(10) 飼料中の乳酸菌の死菌体又はその処理物の濃度が、 0を超え 20 00 ppm以下であることを特徴とする上記 (9) 記載の魚介類用飼料、  (10) The feed for fish and shellfish according to (9) above, wherein the concentration of dead lactic acid bacteria or the processed product thereof in the feed is more than 0 and not more than 2000 ppm
(11) 上記 (1) 〜 (8) のいずれかに記載の魚介類用抗ストレス剤を 魚介類に給餌することを特徴とする魚介類のストレスの予防又は治療方法、 (12) 乳酸菌の死菌体又はその処理物を魚介類に魚介類体重 1 k g当た り 1日 0. 0005〜75mg給餌することを特徴とする魚介類のストレスの 予防又は治療方法、  (11) A method for preventing or treating seafood stress, comprising feeding the seafood with the antistress agent for seafood according to any one of (1) to (8) above, (12) Death of lactic acid bacteria A method for preventing or treating stress in seafood, characterized by feeding the body or processed product thereof to seafood at a rate of 0.0005 to 75 mg per day per kg of seafood;
(13) 上記 (1) 〜 (8) のいずれかに記載の魚介類用抗ストレス剤を 使用することを特徴とする魚介類の血清コルチゾール上昇抑制方法、  (13) A method for suppressing a rise in serum cortisol in seafood, comprising using the antistress agent for seafood according to any one of (1) to (8) above,
(14) 上記 (1) 記載の魚介類用抗ストレス剤を使用することを特徴と する魚介類の養殖方法、  (14) A method for cultivating seafood characterized by using the antistress agent for seafood described in (1) above,
(15) 魚介類の味質が改善される上記 (14) 記載の養殖方法、 及び (15) The aquaculture method described in (14) above, wherein the taste quality of seafood is improved, and
(16) 養殖魚介類の生残率が改善される上記 (14) 又は (15) に記 載の養殖方法、 (16) The aquaculture method described in (14) or (15) above, wherein the survival rate of cultured seafood is improved,
に関する。 発明を実施するための最良の形態 About. BEST MODE FOR CARRYING OUT THE INVENTION
本発明において乳酸菌としては、公知の乳酸菌、例えば、ラクトバチルス属、 ストレプトコックス属、 ェンテロコッカス属、 ラクトコッカス属又はビフィズ ス属する乳酸菌のいずれをも用いることができる。 さらに詳しくは、 ラクトバ チルス 'プラン夕ラム (Lactobacillus pi ant arum)、 ラクトバチラス 'ァシド フィ ラス (Lactobacillus acidophilus) , ラク トノ チルス · ブレビス (Lactobacillus brevis) , ラク卜 ^チレス ·力セィ (Lactobacillus casei)、 ラクトバチルス ·フアーメンタム (Lactobacillus fermentum), ラクトバチル ス ·パラカゼィ (Lactobacillus paracasei)、 ラクトバチルス · ブフネリ (Lactobacillus buchneri)、 ラク卜ノ チノレス · ^レブリレッキー (Lactobacillus delbruecki i)、 ラクトノ チレス -ラムノサス (Lactobacillus rhamosus), ス トレプトコッカス 'サ一モフィラス(Streptococcus thermophilus) , ェンテロ コッカス 'フエ一力リス (Enterococcus faecalis)、 ェンテロコッカス 'ファ シゥム (Enterococcus faecium)、 ラクトコッカス ·ラクテイス (Lactococcus lactis)、 ラクトコッカス 'プラン夕ラム (Lactococcus plantarum) 又はビフ イ ドバクテリゥム ·サ一モフィラム (Bifidobacterium thermophilum)、 ビフ ィ ドバクテリゥム · ロンガム (Bifidobacterium longum), ビフィドバクテリ ゥム ·ブレービ (Bifidobacterium breve) などが挙げられる。 これら各種乳 酸菌のうち、 ラクトバチルス ·プラン夕ラム (Lactobacillus plantarum) が 好ましい。  In the present invention, as the lactic acid bacteria, any known lactic acid bacteria such as Lactobacillus genus, Streptococcus genus, Enterococcus genus, Lactococcus genus or Bifidobacterium can be used. In more detail, Lactobacillus pi ant arum, Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus brevis, Lactobacillus casei, Lactobacillus casei, Lactobacillus fermentum, Lactobacillus paracasei, Lactobacillus buchneri, Lactobacillus buchneri, Lactobacillus delbruecki i, Lactobacillus delbruecki i, Lactobacillus Streptococcus thermophilus, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Lactococcus lactis (Lactococcus plantarum), Bifidobacterium thermophilum, Bifidobacterium longum, Bifidobacterium breve and the like. Of these various lactobacilli, Lactobacillus plantarum is preferred.
本発明に用いられるラクトバチルス ·プランタラムに属する菌の代表的なも のとしてラクトバチルス ·プランタラム L一 137を挙げることができるが、 この菌は、 独立行政法人産業技術総合研究所 特許生物寄託センターに、 受託 番号 FERM BP— 08607号 (平成 7年 11月 30日に寄託された FE RM P— 15317号より移管) として寄託されている。 本発明で用いられ るラクトバチルス ·プランタラムには、 さらにラクトバチルス ·プランタラム (Lactobaci l lus pi ant arum) J CM 1 1 4 9基準株およびラクトバチルス · プランタラム L— 0 5 1 (微ェ研菌寄第 1 1 9 1 2号) が含まれる。 ラクトバ チルス ·プラン夕ラム L— 1 3 7が最も好ましい。 Lactobacillus plantarum L 1 137 can be mentioned as a representative of the bacteria belonging to Lactobacillus plantarum used in the present invention. This bacteria is an independent administrative agency, National Institute of Advanced Industrial Science and Technology. Deposited at the center under the deposit number FERM BP-08607 (transferred from FE RM P-15317 deposited on November 30, 1995). The Lactobacillus plantarum used in the present invention further includes Lactobacillus plantarum. (Lactobacillus pi ant arum) JCM 1 1 4 9 Reference strain and Lactobacillus plantarum L— 0 5 1 (Microbiken No. 1 1 9 1 2) are included. Lactobacillus planum lamb L— 1 3 7 is most preferred.
上記の本発明に用いる菌は天然培地、 合成培地、 半合成培地などの培地に培 養することにより得ることができる。 培地としては、 窒素源および炭素源を含 有するものが用いられる。 窒素源としてはたとえば、 肉エキス、 ペプトン、 グ ルテン、 カゼイン、 酵母エキス、 アミノ酸等であり、 炭素源としては、 たとえ ば、 グルコース、 キシロース、 フラク 1 ^一ス、 イノシ! ル、 マルトース、 水 ァメ、、 麹汁、 澱粉、 バカス、 フスマ、 糖蜜、 グリセリン等が用いられる。 こ のほか、 無機質として、 たとえば硫酸アンモニゥム、 リン酸カリウム、 塩化マ グネシゥム、 食塩、 鉄、 マンガン、 モリブデンなどを添加することができ、 更 に各種ビタミン類その他を添加することができる。 培養温度は約 2 5〜4 0 °C、 好ましくは約 2 7〜3 5 °Cであり、 培養時間は約 1 2〜4 8時間程度であり、 通気振盪してもよい。 培地の p Hは約 3〜6、 好ましくは約 4〜6である。 培養終了後、 菌体を採取した後、 死菌体を調製してもよいし、 又は菌体を培 養液から一旦分離することなく、 培養液中の菌体を死菌体にし、 その死菌体を 採取してもよい。菌体を採取する方法としては、例えば培養液に蒸留水を加え、 遠心分離などの手段により上清を除き、 必要によりその操作を繰り返し、 遠心 分離や濾過等により菌体を採取する方法がある。 死菌体は、 採取された生菌ぁ るいは生菌を含んだ培養液ごと、 たとえば加熱、 紫外線照射、 ホルマリン処理 などにより不活性化することにより得られる。 加熱処理により死菌体を得る場 合、 加熱温度は通常約 6 0〜1 0 0 °C、 好ましくは約 7 0〜9 である。 加 熱手段としては、 ヒーターを用いる公知の手段であってよい。 加熱時間は所望 の温度に達した後、 通常約 5〜4 0分、 好ましくは約 1 0〜3 0分である。 死 菌体の処理物は、 例えば、 死菌体を凍結乾燥や噴霧乾燥することによって得ら れる。また、死菌体にデキストリンゃセルロースなどの適当な賦形剤を加えて、 これを凍結乾燥や噴霧乾燥することによつても得られる。 死菌体の処理物はま た、 死菌体の抽出物であってもよい。 The bacterium used in the present invention can be obtained by culturing in a medium such as a natural medium, a synthetic medium, or a semi-synthetic medium. A medium containing a nitrogen source and a carbon source is used as the medium. Nitrogen sources include, for example, meat extract, peptone, gluten, casein, yeast extract, amino acids, etc., and carbon sources include, for example, glucose, xylose, flax 1 ^ 1s, wild boar, maltose, water Me, soup, starch, bacus, bran, molasses, glycerin, etc. are used. In addition, for example, ammonium sulfate, potassium phosphate, magnesium chloride, sodium chloride, iron, manganese, molybdenum, and the like can be added as inorganic substances, and various vitamins and the like can be added. The culture temperature is about 25 to 40 ° C, preferably about 27 to 35 ° C, the culture time is about 12 to 48 hours, and aeration and shaking may be performed. The pH of the medium is about 3-6, preferably about 4-6. After completion of the culture, the cells may be collected and then killed cells may be prepared, or the cells in the culture solution may be changed to dead cells without separating the cells from the culture solution. Bacteria may be collected. As a method for collecting the bacterial cells, for example, there is a method in which distilled water is added to the culture solution, the supernatant is removed by means such as centrifugation, the operation is repeated as necessary, and the bacterial cells are collected by centrifugation or filtration. . Dead cells can be obtained by inactivating the collected live cells or the culture medium containing the live cells, for example, by heating, ultraviolet irradiation, formalin treatment, or the like. When dead cells are obtained by heat treatment, the heating temperature is usually about 60 to 100 ° C., preferably about 70 to 9. The heating means may be a known means using a heater. The heating time is usually about 5 to 40 minutes, preferably about 10 to 30 minutes after reaching the desired temperature. The treated product of dead cells can be obtained, for example, by freeze-drying or spray-drying dead cells. In addition, add appropriate excipients such as dextrin and cellulose to dead cells, This can also be obtained by freeze drying or spray drying. The processed product of dead cells may also be an extract of dead cells.
本発明における魚介類としては、 特に限定されず、 淡水魚、 海水魚、 甲殻類 のいずれであってもよく、また、養殖魚類、観賞魚類のいずれであってもよい。 淡水魚としては、 ゥナギ、 コィ、 ニジマス、 ァュ、 ティラピア、 フナ、 金魚類 (例えば、 ランチユウ、 和金、 コメット、 朱文金、 オランダシシガシラ、 出目 金等)、 グッピー、 ァピストグラマ、 デイスカス等が挙げられ、 海水魚として は、 クロマグロ、 プリ、 タイ、 ギンザケ、 マアジ、 ヒラメ、 カレイ、 クロソィ、 トラフグ、 カンパチ等が挙げられる。 また、 淡水魚及び海水魚のいずれにも属 するものとして、サケ 'マス類等が挙げられる。甲殻類としては、クルマエビ、 ブラックタイガ一、 ゥシェビ、 コゥライェビ、 ガザミ等が挙げられる。  The seafood in the present invention is not particularly limited, and may be any of freshwater fish, saltwater fish, and crustaceans, and may be any of cultured fish and ornamental fish. Examples of freshwater fish include eel, carp, rainbow trout, ayu, tilapia, crucian carp, goldfish (e.g., lunchyu, Japanese gold, comet, vermilion gold, Dutch shigashira, dice, etc.), guppy, apistogramma, and dish. Examples of saltwater fish include bluefin tuna, puri, Thailand, coho salmon, horse mackerel, flounder, flounder, blackfish, trough, and amberjack. In addition, salmon trout and the like can be mentioned as belonging to both freshwater fish and saltwater fish. Examples of crustaceans include prawns, black taiga, ushebi, kolayebi, and crab.
上記のような魚介類は、 仔稚魚 (小魚、 子魚、 稚魚、 幼魚を含む)、 成魚の いずれであってもよい。  The seafood as described above may be any of larvae (including small fish, larvae, fry, and juveniles) and adult fish.
本発明の抗ストレス剤は、 ·乳酸菌の死菌伴又はその処理物そのものであって よいし、 死菌体又はその処理物を賦形剤又は希釈剤と混合した製剤であっても よい。 製剤全体に対する死菌体又はその処理物の配合割合は好ましくは約 0 . 0 1〜9 5質量%でぁり、 より好ましくは約 0 . 1〜 5 0質量%である。 剤型 としては、 ペレット剤、 錠剤、 液剤、 粉剤、 粒剤、 ペースト剤などが挙げられ る。 そのような製剤は魚介類に接触させたり、 経口で与えることができる。 固状の賦形剤又は希釈剤としては、 例えば、 魚粉、 骨粉、 スキムミルク、 綿 実粕、 小麦粉、 小麦胚芽、 米ぬか、 ビール酵母、 セルロース、 ビタミン類 (例 えば /3—力ロチン、 ビタミン D 3、 メナジオン—亜硫酸水素ナトリウム、 — トコフエロール、 チアミン—硝酸塩、 リボフラビン、 ピリドキシン—塩酸塩、 シァノコバラミン、 ピオチン、 イノシトール、 ニコチン酸、 パントテン酸カル シゥム、 葉酸、 塩ィ匕コリン、 パラアミノ安息香酸又はビタミン C等)、 ミネラ ルミックス類 (例えば硫酸マグネシウム、 リン酸 2ナトリウム、 リン酸 2ナト リウムカリウム、 クェン酸鉄、 乳酸カルシウム、 水酸化アルミニウム、 硫酸亜 鉛、 硫酸銅、 硫酸マンガン、 ヨウ素酸カルシウム又は硫酸コバルト等) などの いわゆる飼料原料が挙げられる。 液状の賦形剤又は希釈剤としては、 水あるい は水とアルコールとの混合物などが挙げられる。 本発明の抗ストレス剤は、 ラ クトバチルス ·プランタムの死菌体又はその処理物を上記した賦形剤又は希釈 剤と混合することによって容易に製造できる。 混合に際して、 所望により加熱 し、 フレーク状製剤を得ることもできる。 このようにして製造された本発明の 製剤は、 魚介類用の飼料として使用されてよい。 飼料として使用される場合、 飼料中の死菌体又はその処理物の濃度は、好ましくは約 0 p p mを超え 2 0 0 0 p p m以下であり、 より好ましくは約 0 . l〜2 0 0 p p mである。 The anti-stress agent of the present invention may be a killed lactic acid bacterium or a processed product thereof, or a preparation obtained by mixing dead cells or a processed product thereof with an excipient or diluent. The blending ratio of dead cells or processed product thereof to the whole preparation is preferably about 0.1 to 95% by mass, more preferably about 0.1 to 50% by mass. Examples of the dosage form include pellets, tablets, liquids, powders, granules, and pastes. Such preparations can be brought into contact with seafood or given orally. Solid excipients or diluents include, for example, fish meal, bone meal, skim milk, cottonseed meal, wheat flour, wheat germ, rice bran, brewer's yeast, cellulose, vitamins (eg / 3-strength rotin, vitamin D 3 , Menadione-sodium hydrogen sulfite, —tocopherol, thiamine—nitrate, riboflavin, pyridoxine—hydrochloride, cyanocobalamin, piotin, inositol, nicotinic acid, calcium pantothenate, folic acid, choline choline, paraaminobenzoic acid or vitamin C Etc.), mineral mixes (eg magnesium sulfate, disodium phosphate, 2-natto phosphate) And so-called feed materials such as potassium potassium, iron citrate, calcium lactate, aluminum hydroxide, sulfite sulfate, copper sulfate, manganese sulfate, calcium iodate or cobalt sulfate). Examples of the liquid excipient or diluent include water or a mixture of water and alcohol. The antistress agent of the present invention can be easily produced by mixing dead bacteria of Lactobacillus plantum or a processed product thereof with the above-mentioned excipient or diluent. When mixing, it may be heated as desired to obtain a flaky preparation. The preparation of the present invention thus produced may be used as a feed for seafood. When used as feed, the concentration of dead cells in the feed or processed product thereof is preferably more than about 0 ppm and not more than 200 ppm, more preferably from about 0.1 to 200 ppm. is there.
本発明の魚介類用抗ストレス剤の給餌量は、 上記乳酸菌の死菌体又はその処 理物に換算して、 魚介類の体重 1 k g当たり 1日 0 . 0 0 0 5〜7 5 m gであ るのが好ましく、 0 . 0 0 5〜7 . 5 m gであるのがより好ましい。  The feeding amount of the antistress agent for seafood of the present invention is 0.05 to 75 mg per day per kg body weight of the seafood in terms of the above-mentioned dead cells of lactic acid bacteria or processed products thereof. It is preferable that it is 0.05 to 7.5 mg.
本発明製剤の魚介類に対する抗ストレス作用のメカニズムは、 その一つとし て、 血清コルチゾ一ル上昇抑制によるものが考えられる。 ス小レスを受けた場 合、 まずストレスに対して神経 ·内分泌系が反応し、 神経伝達物質やホルモン を分泌する。 分泌された神経伝達物質やホルモンの持つ生理作用によって体内 で生理的な変化が起こり、 その生理的変化に伴い、 成長の阻害、 生殖機能低下 及び病気に対する抵抗性の低下が生じ得る。 これらストレスの影響は、 神経伝 達物質、 ホルモンなどいろいろな物質の統合による結果であるが、 その主役を 演じているのはコルチゾールであるといわれている (養殖 2001. No. 1 1、 56 - 59)。 ゆえに、 前述したようなストレスによる悪影響に抵抗するためには、 コルチゾールの上昇を抑制することによって可能である。  One possible mechanism for the anti-stress effect of the preparation of the present invention on fish and shellfish is to suppress the rise in serum cortisol. In the event of a small stress, the neuro-endocrine system first responds to stress and secretes neurotransmitters and hormones. Physiological effects of secreted neurotransmitters and hormones can cause physiological changes in the body, which can lead to growth inhibition, reproductive function and decreased resistance to disease. The effects of these stresses are the result of the integration of various substances such as neurotransmitters and hormones, but it is said that cortisol plays the leading role (cultured 2001. No. 1 1, 56- 59). Therefore, it is possible to resist the adverse effects of stress as described above by suppressing the rise in cortisol.
本発明の魚介類用抗ストレス剤は、 魚介類のコルチゾールの上昇を抑制する 作用があり、 魚介類に投与すると魚介類のストレスを有効に予防又は治療する ことができる。 この結果、 魚介類の体重が増加し、 魚介類の成長が増進され、 生存率がアップし、 魚介類の味質 (例えば食感、 風味等) が改善される。 実施例 1 The antistress agent for seafood of the present invention has an action of suppressing the rise of cortisol in seafood, and when administered to seafood, the stress of seafood can be effectively prevented or treated. As a result, the weight of seafood increases, the growth of seafood increases, The survival rate is improved and the taste quality of seafood (eg, texture, flavor, etc.) is improved. Example 1
[ラクトバチルス ·プラン夕ラム L— 137株 (Lactobacillus plantarum L- 137) の死菌体を含むペレツト剤の製造]  [Manufacture of pellets containing dead cells of Lactobacillus plantarum L-137]
(菌の培養)  (Bacteria culture)
グルコース 1 %、酵母エキス 1 %、ポリペプトン 0.5%、肉エキス 0.2%、 酢酸ナトリウム 0. 2%、 硫酸マンガン · 4水和物 0. 001%、 硫酸鉄 · 7 水和物 0. 001%、 食塩0. 001%、 ショ糖脂肪酸エステル 0. 05%含 む培地 6 Lにラクトバチルス ·プランタラム L— 137 (受託番号 FERM BP— 08607) 株を接種し、 32 で 24時間培養した。 培養後、 培養液 を 5000 r pmで 35分間遠心分離し菌体を集めた。 得られた菌体を生理食 塩水によく分散し、 5000 r pmで 35分間遠心分離した後、 上清を除き、 菌体を集めた。 この操作を 3回繰り返した後、 菌体をイオン交換水に分散し、 70°C10分間加熱した後、 凍結乾燥することにより加熱死菌体を約 7 g得た。 (死菌体からペレツト剤の製造)  1% glucose, 1% yeast extract, 0.5% polypeptone, 0.2% meat extract, 0.2% sodium acetate, manganese sulfate tetrahydrate 0.001%, iron sulfate heptahydrate 0.001%, salt Lactobacillus plantarum L-137 (Accession No. FERM BP-08607) strain was inoculated into 6 L of a medium containing 0.001% and 0.05% sucrose fatty acid ester, and cultured at 32 for 24 hours. After culturing, the culture was centrifuged at 5000 rpm for 35 minutes to collect the cells. The obtained bacterial cells were well dispersed in physiological saline and centrifuged at 5000 rpm for 35 minutes, and then the supernatant was removed to collect the bacterial cells. After repeating this operation three times, the cells were dispersed in ion-exchanged water, heated at 70 ° C. for 10 minutes, and then freeze-dried to obtain about 7 g of heated dead cells. (Manufacture of pellets from dead cells)
ブラウンフィッシュミール 65. 6質量部、 —スターチ 3. 4質量部、 デ キストリン 3. 4質量部、 ダイズレシチン 4. 2質量部、 メナジオン一亜硫酸 水素ナトリウム 0. 01428質量部、 チアミン一硝酸塩 0. 01797質量 部、 リボフラビン 0. 05981質量部、 ピリドキシン一塩酸塩 0. 0142 8質量部、 シァノコバラミン 0. 00002質量部、 セルロース 0. 5986 9質量部、 ピオチン 0. 00181質量部、 イノシトール 1. 19769質量 部、 ニコチン酸 0. 23954質量部、 パントテン酸カルシウム 0. 0838 6質量部、 葉酸 0045質量部、 塩化コリン 2. 44855質量部、 パラ ァミノ安息香酸 0. 11929質量部、 ビタミン CO. 04681質量部、 ミ ネラルミックス 4. 3質量部、 イノシン酸 0. 1質量部、 ベタイン 0. 6質量 部、 ァラニン 0. 4質量部及び活性化ダルテン 5. 0質量部からなる飼料原料 をよく混合し、 キッチンエンドで 10分間混合した。 これに、 ビタミン含有鳕 肝油 (鳕 fF油 7質量部に、 ^一力ロチン 0. 02996質量部、 ビタミン D3 0. 00301質量部、 α—トコフエロール 0. 11993質量部を加え、 超 音波洗浄機を用いて混合したもの) を加えた。 これに、 ラクトバチルス ·ブラ ン夕ラム L_ 137加熱死菌体を所定濃度となるように加えた後、 α—セル口 ースを加え、 全量を 100質量部に調整して死菌体含有飼料とした。 加熱死菌 体の添加濃度は、 死菌体含有飼料中、 それぞれ 0、 0. 2、 2、 20、 200 p pmの 5水準とした。 Brown Fish Meal 65. 6 parts by weight, —Starch 3.4 parts by weight, dextrin 3.4 parts by weight, soy lecithin 4.2 parts by weight, sodium menadione hydrogen bisulfate 0.0124 parts by weight, thiamine mononitrate 0.01797 Parts by mass, riboflavin 0.05991 parts by mass, pyridoxine monohydrochloride 0.014 8 parts by mass, cyanobalamine 0.00002 parts by mass, cellulose 0.5986 9 parts by mass, piotin 0.00191 parts by mass, inositol 1. 19769 parts by mass Nicotinic acid 0.23954 parts by mass, calcium pantothenate 0.00838 6 parts by mass, folic acid 0045 parts by mass, choline chloride 2.44855 parts by mass, paraaminobenzoic acid 0.111929 parts by mass, vitamin CO. 04681 parts by mass, Mineral mix 4.3 parts by weight, inosinic acid 0.1 parts by weight, betaine 0.6 parts by weight The feed material consisting of 0.4 parts by weight, alanine and 5.0 parts by weight activated dartene was mixed well and mixed for 10 minutes at the kitchen end. To this was added vitamin-containing 鳕 liver oil (鳕 fF oil 7 parts by weight, ^ Ichirotin 0.0996 parts by weight, vitamin D 3 0.00301 parts by weight, α-tocopherol 0.111993 parts by weight, ultrasonic washing machine The mixture was added using Lactobacillus branulam L_137 heated dead cells are added to this to a predetermined concentration, then α-cell mouthwater is added, and the total amount is adjusted to 100 parts by mass to feed dead cells. It was. The addition concentration of the heated dead cells was set to 5 levels of 0, 0.2, 2, 20, and 200 ppm in the dead cell-containing feed, respectively.
上記で得られた死菌体含有飼料に水を該飼料に対して 40質量%となるよ うに加え 10分間混ぜ合わせた。 得られた混合物をチョッパーで 2回ひき、 直 径 1. 2mmのペレット状飼料を作製した。 それをオーブンで乾燥させ、 水分 含量が全体の 10%以下にしたものを試験飼料とした。 なお、 上記ミネラルミ ックスの組成を下記第 1表に示す。 Water was added to the dead cell-containing feed obtained above so as to be 40% by mass with respect to the feed and mixed for 10 minutes. The obtained mixture was ground twice with a chopper to prepare a pelleted feed having a diameter of 1.2 mm. This was dried in an oven to make the water content less than 10% of the total as the test feed. The composition of the mineral mix is shown in Table 1 below.
第 1表 Table 1
マダイ稚魚 (体重: 0. 9±0. l g) を、 循環式 30L円形ポリカーポネ —トタンクに 15尾ずつ収容し、 これを各試験飼料当たり 3タンクずっセット し、試験飼料を朝夕の一日二回、体重の 5〜7%を与え、換水率 2. 4LZ分、 水温 20. 0°Cで飼育した。 30日間飼育後、 尾部毛細血管から血液を採取し た。 この血液から血清を調整した後、 血清中のコルチゾ一ル量を EL I S A法 で測定した。 結果を第 2表に示した。 第 2表 Red sea bream larvae (weight: 0.9 ± 0. lg) were placed in a circulating 30L circular polycarbonate tank, 15 each, and 3 tanks were set for each test feed, and the test feed was taken twice a day in the morning and evening. 5-7% of the body weight was given, the water change rate was 2.4 LZ, and the water temperature was maintained at 20. 0 ° C. After 30 days of breeding, blood was collected from the tail capillaries. After preparing serum from this blood, the amount of cortisol in the serum was measured by ELISA. The results are shown in Table 2. Table 2
第 2表からわかるように、 ラクトバチルス ·プラン夕ラム L— 1 3 7株 (Lactobacillus plantarum L- 137) の加熱死菌体を 0. 2 ppm以上含有 した飼料を与えた試験群では、 該加熱死菌体を含有しない飼料を与えた対照群 に比べ、 マダイ血清中のコルチゾールが著しく低値であった。 実施例 2 As can be seen from Table 2, the Lactobacillus plantarum L-1 137 strain (Lactobacillus plantarum L-137) heat-killed cells containing 0.2 ppm or more of the feed group were fed in the test group. Cortisol in red sea bream serum was significantly lower than in the control group that received a diet that did not contain dead cells. Example 2
1. 死菌体処理物の製造  1. Manufacture of dead cells
マルトース 4 %、 ポリヘプトン 2 %、 酵母エキス 2 %、 酢酸ナトリウム 0. 5%、 ポリオキシエチレン (20) ソルビタンモノォレート 0. 05%、 硫酸 マンガン 002%を含有する培地にて、 ラクトバチルス ·プランタラム L - 137 (Lactobacillus plantarum L- 137 ) を 32°Cで 24時間培養し、 培養液を 80 で 20分間加熱処理した。 その後、 加水しながら濾過濃縮装置 にて培養液を洗浄 ·濃縮し、 加熱死菌体溶液を得た。 得られた加熱死菌体溶液 にデキストリンを加え、 噴霧乾燥し、 加熱死菌体を 18 %含む死菌体処理物を 得た。  In a medium containing maltose 4%, polyheptone 2%, yeast extract 2%, sodium acetate 0.5%, polyoxyethylene (20) sorbitan monooleate 0.05%, manganese sulfate 002%, Lactobacillus planon Talam L-137 (Lactobacillus plantarum L-137) was cultured at 32 ° C for 24 hours, and the culture was heat-treated at 80 for 20 minutes. Thereafter, the culture solution was washed and concentrated with a filter concentration device while adding water to obtain a heated dead cell solution. Dextrin was added to the obtained heated dead cell solution and spray-dried to obtain a treated product of dead cells containing 18% of heated dead cells.
2. ペレット剤の製造  2. Manufacture of pellets
1 00 g当たり、 ブラウンフィッシュミール 65. 6 g、 α—スターチ 5. 8 g、 デキストリン 3. 4g、 タラ肝油 5. 2 g、 大豆レシチン 2. O g、 高 度不飽和脂肪酸 1. 0 g、 ビタミンミックス 3. 0 g、 ミネラルミックス 3. 0 g、 ベ夕イン 0. 5 g、 ァラニン 0. 5 g、 カルボキシメルセルロースナト リウム塩 5. 0g、 上記 1で作製した死菌体処理物を 0. O l g (菌体含量と して約 0. 0018 g) 及ぴ α—セルロース 4. 99 g含有する混合物に水道 水を適当量加えさらによく混合し、 ペレツ夕一にて、 直径 2. 5mmの飼料を 作製した。 得られた飼料を 50°Cに設定したオーブン中で水分含量が 10%に なるまで乾燥させ、 これを試験飼料とした。 また、 死菌体処理物をひ—セル口 —スに置き換えて用いたこと以外、 上記試験飼料を製造する方法と同様の方法 で対照飼料を調製した。 Per 100 g, brown fish meal 65.6 g, α-starch 5. 8 g, dextrin 3.4 g, cod liver oil 5.2 g, soy lecithin 2. O g, highly unsaturated fatty acid 1.0 g, vitamin mix 3.0 g, mineral mix 3.0 g, betaine 0 5 g, alanine 0.5 g, carboxymercellulose sodium salt 5.0 g, treated with dead cells produced in 1 above, 0.Olg (bacterial cell content of about 0.0019 g) An appropriate amount of tap water was added to the mixture containing 4.99 g of α-cellulose and mixed well, and a feed with a diameter of 2.5 mm was prepared at Perez Yuichi. The obtained feed was dried in an oven set at 50 ° C. until the water content became 10%, and this was used as a test feed. In addition, a control feed was prepared in the same manner as the method for producing the test feed, except that the dead cell-treated product was replaced with a micellar mouth.
なお、 ビタミンミックスの組成を第 3表に示し、 ミネラルミックスの組成を 第 4表に示した。 The composition of the vitamin mix is shown in Table 3, and the composition of the mineral mix is shown in Table 4.
第 3表 Table 3
ビタミンミックス 3 g当たりに含有するビタミン (mg) Vitamins contained per 3 g of vitamin mix (mg)
β一力ロチン 9.63 ヒタ^ノ D3 0.97 メナン才ノ一亜硫酸水 ナ卜リゥム 4.58 一卜 ノエロー レ 38.5 チノ ノー硝酸塩 5.78 リ^!ヽノフ匕ノ 19.24 しヒ0 ϊリ 1 卜千^- : ,、 , Α τΈϋ^Α塩^ β-strength rotin 9.63 Hitano D 3 0.97 Menanian monosulfite aqueous solution Narium 4.58 Ichino Noel Les 38.5 Chino Nitrate 5.78 Li ^! ヽ Nofuno 19.24 Shihi 0 ϊri 1 Thousand ^-:, ,, Έϋ τΈϋ ^ ΑΑ
ンノ一塩酸 4.58 ン/ ノ_ (/、フ^ノ 0.01 Nnomonohydrochloric acid 4.58 N
1 レロース 192.45 ヒ ナノ 0.58 つ ノン卜一づレ 384.92 ίナノ酸 76.97 パントテン酸カルシウム 26.95 葉酸 1.44 塩化コリン 786.93 パラアミノ安息香酸 38.33 ァスコルビン酸一 2—リン酸エステルナトリゥムカルシウム 28.57 1 Relose 192.45 Hinano 0.58 N / A 384.92 ί Nano acid 76.97 Calcium pantothenate 26.95 Folic acid 1.44 Choline chloride 786.93 Paraaminobenzoic acid 38.33 Ascorbic acid mono 2-phosphate sodium calcium 28.57
第 4表 Table 4
ミネラルミックス 3 g当たりに含有するミネラル (mg)  Mineral mix per 3 g mineral (mg)
45L水槽中にヒラメ稚魚 (体重: 2 3. 5 g) を 5匹ずつ収容し、 1週 間飼育した。 飼育に際し、 対照群 (水槽数 =2) には、 対照飼料を与え、 試験 群 (水槽数 =2) には、 ラクトバチルス 'プラン夕ラム L一 137株加熱死菌 体量に換算して、 0. 036mg/kgノ日になるように試験飼料を与えた。 飼育後、 ヒラメ稚魚を室温 20°C、 湿度 70%の室内で、 空気中に 20分間 露出することにより、 ストレスを負荷した後、 回復水槽 (1L) に移し、 安定 状態 (稚魚が正常に泳ぐ状態) に回復するまでの時間を測定した。 Five flounder larvae (weight: 23.5 g) were housed in 45L aquariums and bred for 1 week. At the time of breeding, the control group (number of tanks = 2) was given a control feed, and the test group (number of tanks = 2) was converted to the amount of Lactobacillus prunum lamb L-1 137 heated dead cells. The test diet was given at 0.36 mg / kg day. After breeding, the flounder larvae were exposed to the air for 20 minutes in the air at room temperature 20 ° C and humidity 70%. After being stressed, they were transferred to the recovery tank (1L) and stabilized (the fry swims normally). Time until recovery to the state) was measured.
その結果、 対照群での回復時間は平均 26. 2分であったのに対し、 試験群 (ラクトバチルス 'プラン夕ラム L一 137株加熱死菌体摂取群) での回復時 間は平均 18. 9分であった。 このことから、 ラクトバチルス .プランタラムAs a result, the recovery time in the control group averaged 26.2 minutes, while the recovery time in the test group (Lactobacillus pranyurum L-1 137 strain heated dead cell intake group) The mean was 18.9 minutes. From this, Lactobacillus plantarum
L- 137株加熱死菌体を給餌することにより、 回復時間が著しく短縮され、 稚魚のストレスに対する抵抗性が高まったことがわかる。 It can be seen that feeding the L-137 strain heat-killed cells significantly shortened the recovery time and increased the resistance of fry to stress.
実施例 3 Example 3
100 g当たり、ブラウンフィッシユミ一ル 70 g、 ひ一スターチ 3.8 g、 デキストリン 3. 5g、 タラ肝油 5. 7g、 ビタミンミックス 3. 0g、 ミネ ラルミックス 3. 0g、 ベ夕イン 0. 5g、 ァラニン 0. 5g、 カルボキシメ ルセルロースナトリウム塩 5. 0g、 実施例 2で作製した死菌体処理物を 0. 01 g (菌体含量として 0. 0018 g) 及びひ—セルロース 4. 99g含有 する混合物に水道水を適当量加えさらによく混合し、ペレツ夕一にて、直径 3. 5mm飼料を作製した。 得られた飼料を 50°Cに設定したオーブン中で水分含 量が 10%になるまで乾燥させ、 これを試験飼料とした。 また、 死菌体処理物 をひ—セルロースに置き換えて用いたこと以外、 上記試験飼料を製造する方法 と同様の方法で対照飼料を調製した。  Per 100 g, brown fish meal 70 g, hii starch 3.8 g, dextrin 3.5 g, cod liver oil 5.7 g, vitamin mix 3.0 g, mineral mix 3.0 g, bayuin 0.5 g, alanine 0.5 g, carboxymethylcellulose sodium salt 5.0 g, a mixture containing 0.01 g of the dead cell processed product prepared in Example 2 (0.0019 g as the cell content) and 4.99 g of cellulose Appropriate amount of tap water was added to and mixed well, and a feed with a diameter of 3.5 mm was prepared at Perez Yuichi. The obtained feed was dried in an oven set at 50 ° C. until the water content became 10%, and this was used as a test feed. In addition, a control feed was prepared in the same manner as the method for producing the test feed except that the dead cell-treated product was replaced with cellulose.
なお、 ミネラルミックスおよびビタミンミックスについては、 それぞれ実施 例 2と同様のものを用いた。  The mineral mix and vitamin mix were the same as in Example 2.
力ンパチ稚魚 (体重: 300〜600g) を 1トン水槽に 7匹ずつ収容して 1週間飼育した。 飼育の際に、 対照群 (水槽数 =2) には、 対照飼料を、 試験 群 (水槽数 =2) には、 ラクトバチルス ·プラン夕ラム L— 137株加熱死菌 体量に換算して 0. 03 emgZkgZ日になるように試験飼料を与えた。 飼育後、 各水槽から無作為に 3匹ずつ取り出し、 刺身にした。 この刺身の味 質 (食感、 外観及び風味) を 15人のパネラーで評価した。 結果を第 5表に示 す。 第 5表 Seven vigorous puffy fry (weight: 300-600g) were housed in a 1-ton aquarium and bred for one week. At the time of breeding, the control group (number of tanks = 2) was converted to the control feed, and the test group (number of tanks = 2) was converted to the Lactobacillus planum lamb L-137 heat dead cell mass. The test feed was given on 0.03 emgZkgZ days. After breeding, three animals were randomly taken from each tank and made into sashimi. The taste (texture, appearance and flavor) of this sashimi was evaluated by 15 panelists. The results are shown in Table 5. Table 5
※ 1名無回答  * No one respondent
外観に関しては、 両群に差は認められないが、 食感、 風味、 並びに食感、 外 観及び風味を総合的に判断した総合評価に関しては、 試験群の方が圧倒的に好 まれることが示された。 特に食感に関しては、 試験群の方が弾力があり、 おい しいとの評価が多く、 また、 試験群の方がコリコリ感があり、 おいしいとの評 価も多かった。 風味に関しても、 試験群の方が生臭みがないといった評価が多 かった。  Regarding the appearance, there is no difference between the two groups, but the test group is overwhelmingly preferred for the overall evaluation of the texture, flavor, and texture, appearance, and flavor. It has been shown. In particular, regarding the texture, the test group was more elastic and delicious, and the test group had a sense of crispiness and was often rated delicious. Regarding the flavor, the test group was more evaluated as having no odor.
力ンパチのような回遊性の魚を水槽内で密集して飼育するとストレス負荷 は強くなり、 味質の低下が予想される。 しかしながら、 ラクトバチルス ·ブラ ン夕ラム L _ l 3 7加熱死菌体を摂取させた場合、 摂取時間が 1週間でも味質 を大きく改善することが可能であることが示された。 このことから、 短期間の 魚介類の飼育 (活け魚料理店等の生け簀での飼育あるいは養殖魚介類等を出荷 する前の飼育等) において、 魚介類の味質を改善できることがわかる。 産業上の利用可能性  If migratory fish such as force napachi are bred in close proximity in the aquarium, the stress load increases and the taste quality is expected to decline. However, when Lactobacillus branrum L_l 3 7 heat-killed cells were ingested, it was shown that the taste quality can be greatly improved even if the intake time is one week. From this, it can be seen that the quality of seafood can be improved in short-term seafood breeding (for example, breeding in a live fish restaurant or before shipping farmed seafood, etc.). Industrial applicability
本発明の抗ストレス剤は、 魚介類のストレスを有効に予防又は治療すること ができる。  The anti-stress agent of the present invention can effectively prevent or treat seafood stress.

Claims

請 求 の 範 囲 1. 乳酸菌の死菌体又はその処理物を含有することを特徴とする魚介類用抗 ストレス剤。  Scope of request 1. Anti-stress agent for seafood characterized by containing dead lactic acid bacteria or processed product thereof.
2. 乳酸菌が、 ラクトバチルス'プランタラム (Lactobacillus plantarum)、 ラクトバチラス 'ァシドフィラス(Lactobacillus acidophilus), ラクトバチ ルス · ブレビス (Lactobacillus brevis)、 ラク トバチルス · カゼィ2. Lactic acid bacteria include Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus brevis, Lactobacillus casei
(Lactobacillus c sein ラクトノ チレス · ファ——メンタム (Lactobacillus fermentum)、 ラクトノ チリレス · / ラカセィ (Lactobacillus paracasei)、 ラ クトバチルス ·ブフネリ (Lactobacillus buchneri)、 ラクトバチルス ·デル ブルツキ一 (Lactobacillus delbrueckii)、 ラクトバチルス · ラムノサス(Lactobacillus c sein, Lactobacillus fermentum), Lactobacillus paracasei, Lactobacillus buchneri, Lactobacillus del brutsuki, Leckobacillus del
(Lactobacillus rhamnosus )、 ス 卜レプトコッカス ' サーモフィ ラス (Streptococcus thermophi lus)、 ェンテロ コ ッカス · フエ一力 リ ス(Lactobacillus rhamnosus), Streptococcus thermophilus, Enterococcus Hue
(Enterococcus faecal is) , ェンテロコッカス · ファシゥム (Enterococcus faecium , ラクトコッカス · ラクテイス (Lactococcus lactis)、 ラクトコッ カス ·プランタラム (Lactococcus pi ant arum), ビフィドバクテリゥム ·サ一 モフィラム (Bifidobacterium thermophi 1 urn), ビフィ ドバクテリゥム ' ロン ガム (Bifidobacterium longum) 又はビフィ ドパクテリゥム · ブレービ(Enterococcus faecal is), Enterococcus faecium, Lactococcus lactis, Lactococcus pi ant arum, Bifidobacterium thermophi Bifidobacterium longum or Bifidobacterium longum
(Bifidobacterium breve) であることを特徴とする請求の範囲第 1項に記載 の魚介類用抗ストレス剤。 2. The antistress agent for fish and shellfish according to claim 1, which is (Bifidobacterium breve).
3. 乳酸菌の死菌体が乳酸菌の加熱処理により得られる死菌体であることを 特徴とする請求の範囲第 1項又は第 2項に記載の魚介類用抗ストレス剤。 3. The antistress agent for fish and shellfish according to claim 1 or 2, wherein the dead cells of lactic acid bacteria are dead cells obtained by heat treatment of lactic acid bacteria.
4. 乳酸菌の死菌体がラク トバチルス · プランタラム L— 1 3 7株 (Lactobacillus plantarum L- 1 37、 受託番号 FERM BP— 08607) の加熱処理死菌体であることを特徴とする請求の範囲第 1項〜第 3項のいず れかに記載の魚介類用抗ストレス剤。 4. Lactic acid bacteria killed by Lactobacillus plantarum L— 1 3 7 4. The anti-seafood product according to any one of claims 1 to 3, which is a heat-treated dead cell of (Lactobacillus plantarum L- 1 37, accession number FERM BP-08607). Stress agent.
5. 魚介類が養殖魚類又は観賞魚類であることを特徴とする請求の範囲第 1 項〜第 4項のいずれかに記載の魚介類用抗ストレス剤。 5. The antistress agent for seafood according to any one of claims 1 to 4, wherein the seafood is a cultured fish or an ornamental fish.
6. 魚介類が、 海水魚又は淡水魚であることを特徴とする請求の範囲第 1項 〜第 5項のいずれかに記載の魚介類用抗ストレス剤。 6. The antistress agent for seafood according to any one of claims 1 to 5, wherein the seafood is saltwater fish or freshwater fish.
7. 魚介類が、 仔稚魚であることを特徴とする請求の範囲第 1項〜第 6項の いずれかに記載の魚介類用抗ストレス剤。 7. The antistress agent for seafood according to any one of claims 1 to 6, wherein the seafood is a larvae and juvenile fish.
8. 乳酸菌の死菌体又はその処理物の配合割合が、 全体量に対して 0. 0 1 〜95質量%であることを特徴とする請求の範囲第 1項〜第 7項のいずれか に記載の魚介類用抗ストレス剤。 8. The proportion of dead lactic acid bacteria or treated product thereof is 0.01 to 95% by mass relative to the total amount, according to any one of claims 1 to 7 The antistress agent for seafood as described.
9. 請求の範囲第 1項〜第 8項のいずれかに記載の魚介類用抗ストレス剤を 含有する魚介類用飼料。 9. A fish and seafood feed comprising the fish and shellfish antistress agent according to any one of claims 1 to 8.
10. 飼料中の乳酸菌の死菌体又はその処理物の濃度が、 0を超え 2000 p pm以下であることを特徴とする請求の範囲第 9項に記載の魚介類用飼料。 10. The feed for fish and shellfish according to claim 9, wherein the concentration of dead lactic acid bacteria or a processed product thereof in the feed is more than 0 and 2000 ppm or less.
1 1. 請求の範囲第 1項〜第 8項のいずれかに記載の魚介類用抗ストレス剤 を魚介類に給餌することを特徴とする魚介類のストレスの予防又は治療方法、 1 1. A method for preventing or treating seafood stress, comprising feeding the seafood with the antistress agent for seafood according to any one of claims 1 to 8,
1 2 . 乳酸菌の死菌体又はその処理物を魚介類に魚介類の体重 1 k g当たり 1日 0 . 0 0 0 5〜7 5 m g給餌することを特徴とする魚介類のストレスの予 防又は治療方法。 1 2. Prevention of stress in fish and shellfish characterized by feeding 0.05 to 7 to 5 mg of lactic acid bacteria dead or processed product to fish and fish per day per kg of fish or seafood Method of treatment.
1 3 . 請求の範囲第 1項〜第 8項のいずれかに記載の魚介類用抗ストレス剤 を使用することを特徴とする魚介類の血清コルチゾール上昇抑制方法。 1 3. A method for inhibiting the elevation of serum cortisol in fish and shellfish, comprising using the antistress agent for fish and shellfish according to any one of claims 1 to 8.
1 4. 請求の範囲第 1項に記載の魚介類用抗ストレス剤を使用することを特 徴とする魚介類の養殖方法。 1 4. A method for cultivating seafood, characterized by using the antistress agent for seafood described in claim 1.
1 5 . 魚介類の味質が改善される請求の範囲第 1 4項に記載の養殖方法。 1 5. The culture method according to claim 14, wherein the taste quality of seafood is improved.
1 6 . 養殖魚介類の生残率が改善される請求の範囲第 1 4項又は第 1 5項に 記載の養殖方法。 1 6. The culture method according to claim 14 or claim 15, wherein the survival rate of the cultured seafood is improved.
PCT/JP2004/003898 2003-03-26 2004-03-22 Antistress agent WO2004084923A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005504047A JP4813902B2 (en) 2003-03-26 2004-03-22 Anti-stress agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003-086419 2003-03-26
JP2003086419 2003-03-26

Publications (1)

Publication Number Publication Date
WO2004084923A1 true WO2004084923A1 (en) 2004-10-07

Family

ID=33095060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/003898 WO2004084923A1 (en) 2003-03-26 2004-03-22 Antistress agent

Country Status (2)

Country Link
JP (1) JP4813902B2 (en)
WO (1) WO2004084923A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018143A1 (en) * 2006-08-10 2008-02-14 House Wellness Foods Corporation Moisturizing agent
CN101278702B (en) * 2007-04-05 2011-03-23 北京大北农科技集团股份有限公司 Novel microbial feed additive and method of producing the same
CN103262952A (en) * 2013-03-14 2013-08-28 盐城工学院 Carassius auratus gibelio anti-stress puffing feed and production method thereof
CN106923080A (en) * 2017-03-08 2017-07-07 广东海洋大学 A kind of feed addictive of the raising Duo anti-transport stress power of Lin Xi juvenile fish
WO2019180263A3 (en) * 2018-03-22 2019-11-28 Adare Pharmaceuticals Sas New use of microbiological compositions
CN110916014A (en) * 2019-11-26 2020-03-27 上海泓宝绿色水产股份有限公司 Oral sunstroke prevention bacterium
WO2022065268A1 (en) * 2020-09-25 2022-03-31 ハウスウェルネスフーズ株式会社 Feed and composition containing lactic acid bacteria and fatty acid
CN114391493A (en) * 2021-12-16 2022-04-26 佛山市顺德区活宝源生物科技有限公司 Method for catching micropterus salmoides
US11571447B2 (en) 2017-05-26 2023-02-07 House Wellness Foods Corporation Composition for preventing, ameliorating or treating metabolic syndrome

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101230876B1 (en) * 2009-02-12 2013-02-07 아트 스크류 코포레이션 리미티드 Fastener and fastening structure
KR20130004268A (en) 2010-02-26 2013-01-09 나고야시 Fastening member and fastening structure

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09308440A (en) * 1996-05-21 1997-12-02 Shimadzu Corp Agent for improving physical constitution of aquatic animal and improvement of physical constitution
JPH1192390A (en) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc Agent for improving stressed state
JP2002080364A (en) * 2000-09-01 2002-03-19 Takeda Food Products Ltd Immunopotentiating composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09308440A (en) * 1996-05-21 1997-12-02 Shimadzu Corp Agent for improving physical constitution of aquatic animal and improvement of physical constitution
JPH1192390A (en) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc Agent for improving stressed state
JP2002080364A (en) * 2000-09-01 2002-03-19 Takeda Food Products Ltd Immunopotentiating composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IIDA TAKATSUGU: "Sakana no stress to seitai bogyo kassei", YOSHOKU, vol. 38, no. 11, 2001, pages 57 - 59, XP002982729 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018143A1 (en) * 2006-08-10 2008-02-14 House Wellness Foods Corporation Moisturizing agent
JPWO2008018143A1 (en) * 2006-08-10 2009-12-24 ハウスウェルネスフーズ株式会社 Moisturizer
US8114658B2 (en) 2006-08-10 2012-02-14 House Wellness Foods Corporation Method of moisturizing skin
JP5121715B2 (en) * 2006-08-10 2013-01-16 ハウスウェルネスフーズ株式会社 Moisturizer
CN101278702B (en) * 2007-04-05 2011-03-23 北京大北农科技集团股份有限公司 Novel microbial feed additive and method of producing the same
CN103262952A (en) * 2013-03-14 2013-08-28 盐城工学院 Carassius auratus gibelio anti-stress puffing feed and production method thereof
CN106923080A (en) * 2017-03-08 2017-07-07 广东海洋大学 A kind of feed addictive of the raising Duo anti-transport stress power of Lin Xi juvenile fish
US11571447B2 (en) 2017-05-26 2023-02-07 House Wellness Foods Corporation Composition for preventing, ameliorating or treating metabolic syndrome
WO2019180263A3 (en) * 2018-03-22 2019-11-28 Adare Pharmaceuticals Sas New use of microbiological compositions
CN110916014A (en) * 2019-11-26 2020-03-27 上海泓宝绿色水产股份有限公司 Oral sunstroke prevention bacterium
WO2022065268A1 (en) * 2020-09-25 2022-03-31 ハウスウェルネスフーズ株式会社 Feed and composition containing lactic acid bacteria and fatty acid
JP7342338B2 (en) 2020-09-25 2023-09-12 ハウスウェルネスフーズ株式会社 Feed and compositions containing lactic acid bacteria and fatty acids
CN114391493A (en) * 2021-12-16 2022-04-26 佛山市顺德区活宝源生物科技有限公司 Method for catching micropterus salmoides
CN114391493B (en) * 2021-12-16 2023-07-04 佛山市顺德区活宝源生物科技有限公司 Fishing method for micropterus salmoides

Also Published As

Publication number Publication date
JPWO2004084923A1 (en) 2006-06-29
JP4813902B2 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
Ghosh et al. Dietary probiotic supplementation in growth and health of live‐bearing ornamental fishes
Abdel-Latif et al. Evaluation of two phytobiotics, Spirulina platensis and Origanum vulgare extract on growth, serum antioxidant activities and resistance of Nile tilapia (Oreochromis niloticus) to pathogenic Vibrio alginolyticus
Seenivasan et al. Enrichment of Artemia nauplii with Lactobacillus sporogenes for enhancing the survival, growth and levels of biochemical constituents in the post-larvae of the freshwater prawn Macrobrachium rosenbergii
KR20170033433A (en) Animal feed compositions and feed additives
Fernandez et al. Effect of lactic acid bacteria administered orally on growth performance of Penaeus indicus (H. Milne Edwards) juveniles
Abdulrahman Evaluation of Spirulina spp. as food supplement and its effect on growth performance of common carp fingerlings
Seenivasan et al. Effects of Probiotics on survival, growth and biochemical characteristics of freshwater prawn Macrobrachium rosenbergii Post Larvae
Ahire et al. Effect of dietary probiotic Lactobacillus helveticus on growth performance, antioxidant levels, and absorption of essential trace elements in goldfish (Carassius auratus)
Bhavan et al. Basic biochemical constituents and profiles of amino acids in the post larvae of Macrobrachium rosenbergii fed with Spirulina and yeast enriched Artemia
Eissa et al. Assessing the influence of dietary Pediococcus acidilactici probiotic supplementation in the feed of European sea bass (Dicentrarchus labrax L.)(Linnaeus, 1758) on farm water quality, growth, feed utilization, survival rate, body composition, blood biochemical parameters, and intestinal histology
Nekoubin et al. The influence of synbiotic (Biomin Imbo) on growth factors and survival rate of Zebrafish (Danio rerio) larvae via supplementation with biomar
JP4813902B2 (en) Anti-stress agent
Seenivasan et al. Influence of combined probiotics Lactobacillus sporogenes and Bacillus subtilis on survival, growth, biochemical changes and energy utilization performance of Macrobrachium rosenbergii (De Man 1879) post larvae
JP2019182763A (en) Composition, and food and feed containing the same
Salama et al. Effect of adding Pediococcus acidilactici at low plant protein diets on growth performance of Nile tilapia (Oreochromis niloticus) fingerlings
Sinha et al. Probiotic effect of a live bacterial isolate in nutrition of an Indian major carp, rohu (Labeo rohita)
Gupta et al. Effect of dietary probiotic improval (Lactobacillus sporogenes and Saccharomyces cerevisiae) on growth and feed utilization of Macrobrachium rosenbergii post larvae
WO2004084922A1 (en) Infection inhibitor for fishes and shellfishes
Adipu et al. Growth performance of Litopenaeus vannamei grown in biofloc system produced from different carbohydrate sources.
KR102147761B1 (en) Quail Breeding Method
JP2022107922A (en) Composition for controlling enterobacterial flora
CN111418712A (en) Feed additive for improving survival rate of weever and preparation method thereof
Falaye et al. Influence of Lactobacillus plantarum supplemented diet on growth response, gut morphometry and microbial profile in gut of Clarias gariepinus fingerlings
Asadian et al. Growth promoting effects of a multi-strain probiotic on common carp (Cyprinus carpio) fingerlings
Al-Faragi et al. Effect of local probiotic on common carp Cyprinus carpio growth performance and survival rate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005504047

Country of ref document: JP

122 Ep: pct application non-entry in european phase
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)